Gilead Sciences (GILD) EBITDA Margin (2009 - 2026)
Gilead Sciences' EBITDA Margin came in at -124.26% for Q2 2026, down 168.95 percentage points from 44.69% a year earlier and down 171.31 percentage points from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported EBITDA Margin of 0.86%, down 36.63 percentage points year-over-year; for FY2025, it was 43.41%, up 28.01 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +20.93 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 15.40% in FY2024 (-22.57 pp), 37.98% in FY2023 (+3.40 pp), 34.58% in FY2022 (-9.25 pp) and 43.83% in FY2021 (+21.35 pp).
- The Q2 2026 figure represents the lowest quarterly EBITDA Margin in data going back to Q1 2009.
- Year-over-year, EBITDA Margin increased in four of the last eight quarters, with an average year-over-year change of -8.09 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q1 2025 (a gain of 98.32 percentage points), and the weakest in Q2 2026 (a drop of 168.95 percentage points).
- Business Quant data shows GILD's EBITDA Margin at 47.05% (Q1 2026), 33.70% (Q4 2025) and 51.65% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 7.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124.26% |
| Mar 31, 2026 | 47.05% |
| Dec 31, 2025 | 33.70% |
| Sep 30, 2025 | 51.65% |
| Jun 30, 2025 | 44.69% |
| Mar 31, 2025 | 43.99% |
| Dec 31, 2024 | 41.55% |
| Sep 30, 2024 | 20.91% |
| Jun 30, 2024 | 48.00% |
| Mar 31, 2024 | -54.32% |
| Dec 31, 2023 | 32.33% |
| Sep 30, 2023 | 46.90% |
| Jun 30, 2023 | 35.55% |
| Mar 31, 2023 | 36.92% |
| Dec 31, 2022 | 37.83% |
| Sep 30, 2022 | 47.74% |
| Jun 30, 2022 | 40.80% |
| Mar 31, 2022 | 10.96% |
| Dec 31, 2021 | 20.36% |
| Sep 30, 2021 | 58.82% |
API Access
Gilead Sciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();